What is Dianthus Therapeutics's common stock?

Dianthus Therapeutics (DNTH) reported common stock of $54K in Q1 2026.

How has Dianthus Therapeutics's common stock changed year-over-year?

Dianthus Therapeutics's common stock increased by 68.8% year-over-year, from $32K to $54K.

What is the long-term trend for Dianthus Therapeutics's common stock?

Over 5 years (2020 to 2025), Dianthus Therapeutics's common stock has grown at a -2.6% compound annual growth rate (CAGR), from $49K to $43K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Dianthus Therapeutics DNTH Common Stock

Common Stock at other companies

AmgenAMGN

2.8B0.0%

Spyre Therapeutics, Inc.SYRE

400M0.0%

Kymera TherapeuticsKYMR

$8K+14.3%

Protagonist TherapeuticsPTGX

$1K0.0%

TG TherapeuticsTGTX

$160K+0.6%

Immunovant, Inc.IMVT

$20K+25.0%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's common stock?: Dianthus Therapeutics (DNTH) reported common stock of $54K in Q1 2026.
How has Dianthus Therapeutics's common stock changed year-over-year?: Dianthus Therapeutics's common stock increased by 68.8% year-over-year, from $32K to $54K.
What is the long-term trend for Dianthus Therapeutics's common stock?: Over 5 years (2020 to 2025), Dianthus Therapeutics's common stock has grown at a -2.6% compound annual growth rate (CAGR), from $49K to $43K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).